Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

doi:10.1016/j.dld.2007.11.024

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

17 Apr 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic factors in colorectal cancer
Share to Genomic variations and chromosomal abnormalities
Share to Multiple and Secondary Primary Cancers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 18294942
DOI: 10.1016/j.dld.2007.11.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinomaPMID 18294942Read ↗

Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinomaSemantic proximity Read ↗

Overexpression of CDT1 Is a Predictor of Poor Survival in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patientsSemantic proximity Read ↗

Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM+ AFP+ hepatocellular carcinomaSemantic proximity Read ↗

Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisSemantic proximity Read ↗

Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent AdvancementsSemantic proximity Read ↗

Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and α-FetoproteinSemantic proximity Read ↗

LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular CarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.